Volcano Corporation (VOLC)
VOLC (NASDAQ:Health Services)
$16.67

-0.07
-0.42%
Today's Range: 16.61 - 17.39 |
VOLC Avg Daily Volume: 1,043,500
| Last Update: 05/22/13 - 4:00 PM EDT |
| Volume: 1,107,729 |
| YTD Performance: -29.10%
|
| Open: $17.21 |
| Previous Close: $16.74 |
| 52 Week Range: $16.37 -
$30.59 |
| Oustanding Shares: 54,540,255 |
| Market Cap: 913,003,869 |
6-Month Chart
TheStreet Ratings Grade for VOLC
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
6 |
6 |
6 |
8 |
| Moderate Buy |
1 |
1 |
1 |
2 |
| Hold |
7 |
6 |
6 |
3 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
1 |
1 |
1 |
| Mean Rec. |
2.07 |
2.21 |
2.21 |
1.86 |
| Latest Dividend: |
0.00 |
| Latest Dividend Yield: |
0.00% |
| Dividend Ex-Date: |
12/31/69 |
| Price Earnings Ratio: |
209.25 |
|
| Price Earnings Comparisons: |
| VOLC |
Sector Avg. |
S&P 500 |
| 209.25 |
186.00 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
-32.14%
|
-42.06%
|
-25.27%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
11.20 |
0.68 |
0.19 |
| Net Income |
-78.90 |
-1.28 |
0.00 |
| EPS |
-78.60 |
-1.25 |
0.00 |
| Earnings for VOLC: |
| EBITDA |
0.05B |
| Revenue |
0.38B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.00 |
$-0.02 |
$0.05 |
$0.28 |
| Number of Analysts |
7 |
7 |
8 |
7 |
| High Estimate |
$0.02 |
$0.00 |
$0.09 |
$0.46 |
| Low Estimate |
$-0.02 |
$-0.06 |
$0.04 |
$0.06 |
| Prior Year |
$0.06 |
$0.04 |
$0.15 |
$0.05 |
| Growth Rate (Year over Year) |
-107.14% |
-160.71% |
-67.50% |
468.50% |
Feb 22, 2013 | 8:12 AM EST
VOLC was downgraded to Market Perform, William Blair said. Company has poor earnings visibility.
Feb 22, 2013 | 7:43 AM EST
VOLC was downgraded from Buy to Neutral, Goldman Sachs said. Company was also cut from the Conviction List. Base business will likely c...
Dec 12, 2012 | 7:46 AM EST
VOLC was downgraded from Outperform to Neutral, Credit Suisse said. $32 price target. Estimates also cut, as the company sold new debt ...
Nov 07, 2012 | 8:22 AM EST
VOLC was downgraded to Market Underperform from Market Perform, JMP Securities said. $20 price target. Longer term fundamentals of PCI ...
Jul 09, 2012 | 6:33 AM EDT
VOLC was initiated with an Outperform rating, Credit Suisse said. $36 price target. Company has a solid growth profile and is a potenti...
May 03, 2012 | 7:59 AM EDT
VOLC was placed on the Conviction Buy list, according to Goldman Sachs. Estimates also boosted, given solid penetration of FM technolog...
Mar 23, 2012 | 7:57 AM EDT
Shares of VOLC upgraded to Buy from Hold, Jefferies said. $37 price target. Rare story in medical devices that checks all the boxes.
Mar 09, 2012 | 7:26 AM EST
VOLC was upgraded from Neutral to Buy, Goldman Sachs said. $36 price target. FFR business should drive growth over the coming quarters....
Feb 23, 2012 | 8:27 AM EST
VOLC was downgraded from Strong Buy to Buy, Feltl & Co. said. Recent guidance has been mixed.
Feb 06, 2012 | 8:05 AM EST
VOLC estimates were boosted through 2015, Goldman Sachs said. Company is gaining market share. Neutral rating and new $28 price target....